NO20063626L - Topisk anvendt medikament for dyr - Google Patents

Topisk anvendt medikament for dyr

Info

Publication number
NO20063626L
NO20063626L NO20063626A NO20063626A NO20063626L NO 20063626 L NO20063626 L NO 20063626L NO 20063626 A NO20063626 A NO 20063626A NO 20063626 A NO20063626 A NO 20063626A NO 20063626 L NO20063626 L NO 20063626L
Authority
NO
Norway
Prior art keywords
animals
used drug
topically used
topically
drug
Prior art date
Application number
NO20063626A
Other languages
English (en)
Norwegian (no)
Inventor
Dirk Mertin
Iris Heep
Gerald Beddies
Nikolaus Kowollik
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20063626L publication Critical patent/NO20063626L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20063626A 2004-01-10 2006-08-10 Topisk anvendt medikament for dyr NO20063626L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004001558A DE102004001558A1 (de) 2004-01-10 2004-01-10 Arzneimittel zur topischen Applikation bei Tieren
PCT/EP2005/000067 WO2005065713A2 (fr) 2004-01-10 2005-01-07 Medicament destine a etre administre a des animaux par voie topique

Publications (1)

Publication Number Publication Date
NO20063626L true NO20063626L (no) 2006-10-10

Family

ID=34744661

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063626A NO20063626L (no) 2004-01-10 2006-08-10 Topisk anvendt medikament for dyr

Country Status (11)

Country Link
US (1) US20080255125A1 (fr)
EP (1) EP1706097A2 (fr)
JP (1) JP5704738B2 (fr)
AU (1) AU2005203884B2 (fr)
BR (1) BRPI0506753A (fr)
CA (1) CA2552909C (fr)
DE (1) DE102004001558A1 (fr)
NO (1) NO20063626L (fr)
NZ (1) NZ548422A (fr)
WO (1) WO2005065713A2 (fr)
ZA (1) ZA200605611B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
CN103315986B (zh) * 2013-05-24 2014-09-03 湖北龙翔药业有限公司 一种可溶且稳定的帕托珠利组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402941A (en) * 1981-09-15 1983-09-06 Marc Vaillancourt Veterinary composition for preventing feline urological syndrome and litter product containing the composition
IN172468B (fr) * 1990-07-14 1993-08-14 Asta Medica Ag
US5122377A (en) * 1990-11-19 1992-06-16 A.H. Robins, Company, Incorporated Oral delivery system for veterinary drugs
EP0684759A4 (fr) * 1992-09-30 1996-05-08 Cornell Res Foundation Inc Fruits pomaces transgeniques possedant une resistance au feu bacterien.
JP2000510842A (ja) * 1996-05-10 2000-08-22 ファルマシア・アンド・アップジョン・カンパニー 全身性細菌疾患の治療のための抗菌剤の局所投与
US5929086A (en) * 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
HK1043019B (zh) * 1998-10-08 2005-05-13 高新研究公司 用於预防和治疗原虫病的组合物和方法
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
AU5315000A (en) * 1999-06-03 2000-12-28 Gregory M. Glenn Indicators for monitoring the technique of transcutaneous immunization
MXPA02000997A (es) * 1999-08-03 2003-10-14 Awd Pharma Gmbh & Co Kg Uso de flupirtina para aliviar el dolor ocasionado por enfermedades degenerativas de las articulaciones en perros y gatos.
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
DE10255415A1 (de) * 2002-11-28 2004-06-09 Bayer Healthcare Ag Dermale Applikation von Flupirtin
PL378713A1 (pl) * 2003-01-16 2006-05-15 Janssen Pharmaceutica N.V. Kompozycje przeciwpierwotniakowe, zawierające diklazuryl

Also Published As

Publication number Publication date
AU2005203884B2 (en) 2011-04-14
EP1706097A2 (fr) 2006-10-04
DE102004001558A1 (de) 2005-08-18
JP5704738B2 (ja) 2015-04-22
BRPI0506753A (pt) 2007-05-22
US20080255125A1 (en) 2008-10-16
NZ548422A (en) 2010-04-30
WO2005065713A2 (fr) 2005-07-21
ZA200605611B (en) 2007-11-28
CA2552909C (fr) 2014-05-27
CA2552909A1 (fr) 2005-07-21
JP2007519637A (ja) 2007-07-19
WO2005065713A3 (fr) 2006-05-11
AU2005203884A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20080068L (no) Topisk unguale formuleringer
DK1494692T3 (da) Topiske, farmaceutiske sammensætninger, der omfatter proanthocyanidiner, glycyrrhetinsyre og telmestein til behandlingen af dermatitis
BRPI0414581C1 (pt) composto, composição farmacêutica compreendendo o referido composto e uso do referido composto
NO20074295L (no) Substituerte gamma lactamer som terapeutiske midler
NO20076019L (no) Utvortes preparat for hud
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
EA200870019A1 (ru) Лактамовые соединения и способы их применения
CL2007003874A1 (es) Compuestos derivados de benzamida; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades cardiovasculares, hipertension, aterosclerosis, reestenosis, ictus, insuficiencia cardiaca, lesion isquemica, hipertensio
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
NO20075068L (no) Lipocalinprotein
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
EP2349279A4 (fr) Modulateurs d'aldéhyde déshydrogénase et procédés d'utilisation de ceux-ci
NO20070391L (no) Jernsulfatbasert fosfatadsorbent
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
CY1116111T1 (el) Τοπικη συνθεση για τη θεραπεια της ακτινικης κερατωσης
EP2184984A4 (fr) Dérivés de n-(arylamino)arylsulfonamide comprenant des polymorphes en tant qu'inhibiteurs de mek ainsi que compositions, procédés d'utilisation et procédés de préparation de ceux-ci
AR052238A1 (es) Formulacion de tabletas estables
GT200600096A (es) Composicion farmaceutica para el tratamiento del cancer
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
NO20082170L (no) Forbedret testosterongel og fremgangsmate til anvendelse
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
NO20076405L (no) Anvendelse av 24-nor-UDCA

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

FC2A Withdrawal, rejection or dismissal of laid open patent application